|
|
| (11) | Number of the document | C 1951684 |
| (68) | Number of the document | 1951684 |
| (21) | Application number for Supplementary Protection Certificate | PA 2021 509 |
| (22) | Date of filing the application | 2021-05-21 |
| (41) | Date of publication of the application | 2021-06-10 |
| Date of publication of SPC | 2022-09-12 | |
| (24) | Date of coming into effect of SPC | 2026-10-27 |
| (71) |
IMPACT BIOMEDICINES, INC.,
86 Morris Avenue, Summit, New Jersey 07901,
US
|
| (73) |
IMPACT BIOMEDICINES, INC.,
86 Morris Avenue, Summit, New Jersey 07901,
US
|
| (74) |
Aušra PAKĖNIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (93) | EU/1/20/1514, 2021-02-08 |
| (94) | 2031-10-26 |
| (95) | Fedratinibas arba farmaciniu požiūriu priimtina jo druska, arba farmaciniu požiūriu priimtinas jo hidratas, ypač fedratinibo dihidrochlorido monohidratas |
| SPC granted |